🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The TRANQUILITY Trial: Multi-Center Randomized, Double-Masked, Parallel Des...
Status
Completed
Location
University Clinical Health
Start Date
2020-11-21
Trial ID
NCT04674358
Treatments Being Tested
A Multi-Center, Phase 2, Randomized, Double-Masked, Parallel-Group, Vehicle...
Status
Completed
Location
Andover Eye Associates
Start Date
2019-04-23
Trial ID
NCT03916042
This study assesses the efficacy and safety of two concentrations of omavel...
Status
Completed
Location
Harvard Eye Associates
Start Date
2014-05-31
Trial ID
NCT02128113
Reduction of elevated pressure in the eye (Intraocular pressure, or 'IOP') ...
Status
Completed
Location
Arizona Eye Center
Start Date
2020-12-17
Trial ID
NCT04742283
Treatments Being Tested
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Phase 3 Evalu...
Status
Completed
Location
Eye Hospital, Wenzhou Medical University
Start Date
2023-09-27
Trial ID
NCT06045299
This is a first-in-human phase I/II randomized, double-blind, placebo (vehi...
Status
Unknown
Location
Clinica Oftalvist Jerez
Start Date
2017-04-03
Trial ID
NCT03162094
Treatments Being Tested
The purpose of this study is to evaluate whether SkQ1 ophthalmic solutions ...
Status
Completed
Location
Lawrence General Hospital
Start Date
2014-04
Trial ID
NCT02121301
This is a Phase 2, randomized, multicenter, double masked, vehicle controll...
Status
Recruiting
Location
Arizona Eye Center
Start Date
2026-05-12
Trial ID
NCT07503886
The objectives of this study are: To evaluate the safety and efficacy of N...
Status
Completed
Location
Phoenix, AZ
Start Date
2022-12-22
Trial ID
NCT05646719
Treatments Being Tested
The purpose of this study is to determine whether SYL1001 ophthalmic soluti...
Status
Completed
Location
East Tallin Central Hospital
Start Date
2017-05-18
Trial ID
NCT03108664
Treatments Being Tested